Key result
B-cells and B-cell-mediated pathways play a central role in the development and progression of heart failure, making them potential targets for novel therapeutic strategies.
B-cells and their mediated pathways are central mediators in heart failure progression, representing a potential novel therapeutic target.
No takes yet. Share an insight, caveat, or question.
B-cell targeting merits exploration in heart failure; leaves open efficacy and safety in prospective trials.
Cordero‐Reyes et al. (2013) conducted a review in Heart failure. B-cell targeted therapies was evaluated. B-cells and B-cell-mediated pathways play a central role in the development and progression of heart failure, making them potential targets for novel therapeutic strategies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: